Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group

BACKGROUND: Liposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (5-FU/LV) was effective and well-tolerated in patients with metastatic pancreatic adenocarcinoma (mPAC) that progressed on gemcitabine-based therapy in the global NAPOLI-1 trial. Real-world data may further clarify the out...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Yoo, Changhoon, Im, Hyeon-Su, Kim, Kyu-pyo, Oh, Do-Youn, Lee, Kyung-Hun, Chon, Hong Jae, Kim, Joo Hoon, Kang, Myoungjoo, Kim, Ilhwan, Lee, Guk Jin, Oh, Sung Yong, Choi, Younak, Choi, Hye Jin, Kim, Seung Tae, Park, Joon Oh, Ryoo, Baek-Yeol
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6710683/
https://ncbi.nlm.nih.gov/pubmed/31489036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919871126
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky